Taylor David M, Gibbs Bernard F, Kabashi Edor, Minotti Sandra, Durham Heather D, Agar Jeffrey N
Department of Neurology and Neurosurgery, Montreal Neurological Institute and Sheldon Biotechnology Centre, McGill University, Montreal, Quebec H3A 2B4, Canada.
J Biol Chem. 2007 Jun 1;282(22):16329-35. doi: 10.1074/jbc.M610119200. Epub 2007 Mar 27.
One familial form of the neurodegenerative disease, amyotrophic lateral sclerosis, is caused by gain-of-function mutations in the gene encoding copper/zinc superoxide dismutase (SOD-1). This study provides in vivo evidence that normally occurring oxidative modification to SOD-1 promotes aggregation and toxicity of mutant proteins. The oxidation of Trp-32 was identified as a normal modification being present in both wild-type enzyme and SOD-1 with the disease-causing mutation, G93A, isolated from erythrocytes. Mutating Trp-32 to a residue with a slower rate of oxidative modification, phenylalanine, decreased both the cytotoxicity of mutant SOD-1 and its propensity to form cytoplasmic inclusions in motor neurons of dissociated mouse spinal cord cultures.
神经退行性疾病肌萎缩侧索硬化症的一种家族形式,是由编码铜/锌超氧化物歧化酶(SOD-1)的基因功能获得性突变引起的。这项研究提供了体内证据,表明SOD-1正常发生的氧化修饰会促进突变蛋白的聚集和毒性。色氨酸-32的氧化被确定为一种正常修饰,在野生型酶和从红细胞中分离出的具有致病突变G93A的SOD-1中均存在。将色氨酸-32突变为氧化修饰速率较慢的残基苯丙氨酸,可降低突变型SOD-1的细胞毒性及其在解离的小鼠脊髓培养物运动神经元中形成细胞质包涵体的倾向。